This inventor holds 4 USPTO granted patents. Top assignees: Hoffmann-La Roche Inc., Scil Technology Gmbh. Active years: 2004-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2005
Title: Ulrike Leser-Reiff: Innovator in Pharmaceutical Chemistry
Introduction
Ulrike Leser-Reiff is a prominent inventor based in Penzberg, Germany. She has made significant contributions to the field of pharmaceutical chemistry, holding a total of four patents. Her work focuses on developing innovative compounds that have potential therapeutic applications.
Latest Patents
Among her latest patents are the N-monoacylated derivatives of o-phenylenediamines and their analogs, which are recognized for their use as pharmaceutical agents. Additionally, she has developed a melanoma inhibiting activity factor (MIA) that is particularly useful in promoting cartilage and bone repair. This factor, when combined with an osteoinductive protein, serves as a valuable pharmaceutical agent for enhancing bone healing and cartilage repair.
Career Highlights
Ulrike has worked with notable companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and Scil Technology GmbH. Her experience in these organizations has allowed her to advance her research and contribute to the development of innovative medical solutions.
Collaborations
Ulrike has collaborated with esteemed colleagues such as Gerd Zimmermann and Rainer Haag, further enriching her research endeavors and expanding her impact in the field.
Conclusion
Ulrike Leser-Reiff's work exemplifies the spirit of innovation in pharmaceutical chemistry. Her patents and collaborations highlight her commitment to advancing medical science and improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile